Moderna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest results from its trial involving 157 people with advanced skin cancer at the annual meeting of the American Society of Clinical Oncology in Chicago. In the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint inhibitor pembrolizumab (Keytruda)—to achieve potentially life-changing results for melanoma patients. [time-brightcove not-tgx=”true”] In the phase 2 study of patients with stage 3 or stage 4 melanoma who were treated after surgery to remove the bulk of
Hence then, the article about an mrna melanoma vaccine shows promise was published today ( ) and is available onTime ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( An mRNA Melanoma Vaccine Shows Promise )